NASHVILLE. Tenn., June 13, 2022 /PRNewswire/ — OneOncology, the national platform for independent oncology practices, today appointed Thomas Stricker, MD as Medical Director for Precision Medicine. Dr. Stricker will work with partner practices to create workflows that reduce physicians’ burden of genomic test ordering and interpretation, so they have more time to spend with their patients. Dr. Stricker reports to Chief Medical Officer, Davey Daniel, MD.
Stricker will work with practices to to reduce physicians’ burden of genomic test ordering and interpretation.
Stricker says he sees three pillars of assistance for testing that he and his team can provide to physician partners:
1) At order, to make sure the right tests are ordered.
2) At initial result, to make sure that the appropriate therapy is given based on the current data.
3) At recurrence or progression, to identify additional options whether they or standard of care or a clinical trial option.
“The complexity of pathology standards in oncology necessitates a change in the way that results are delivered, such as comprehensive reports that summarize the key data from multiple tests,” Dr. Stricker said. “I am excited to help build systems that can empower our physicians to maximize the value of testing during each stage.”
Dr. Stricker was most recently an Assistant Professor in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University where he founded the Somatic Clinical Sign-out Team and the Clinical Genomics Lab, which generates whole exome and other germline sequencing panels. Dr. Stricker also served as associate director of VANTAGE, the research sequencing core for Vanderbilt.
At Vanderbilt, Dr. Stricker also served on molecular tumor boards and was on the team that founded GENIE, an American Association for Cancer Research initiative for the sharing of genomic cancer sequencing data across institutions. Dr. Stricker has extensive experience in generating and analyzing Next Generation Sequencing data, and in generating and signing out clinical genomic reports.
“Dr. Stricker has extensive experience in genomic sequencing, research and developing data integrations across cancer institutions,” said Davey Daniel, MD, OneOncology’s Chief Medical Officer. “His knowledge, experience and vision are a perfect fit to support our physicians’ abilities to use genomic testing to match the right treatment or trial at the right time – all in oncology practices that are conveniently located close to where patients live.”
Dr. Stricker earned his MD and PhD from Washington University in St. Louis. Following a residency in Anatomical Pathology and a fellowship in Bone and Soft Tissue at The University of Chicago, he joined Dr. Kevin White’s lab in the Institute for Genomics and Systems Biology as a post-doctoral fellow. While there, he developed expertise in generating and analyzing data from the then-new next generation sequencing technologies.
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer. Our goal is to enable community oncology practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. OneOncology supports our platform of community oncology practices through group purchasing, operational optimization, practice growth, and clinical innovation. Our 700 cancer care providers care for 280,000 patients at 181 sites of care nationwide. To learn more, visit oneoncology.com or LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/dr-thomas-stricker-joins-oneoncology-as-medical-director-for-precision-medicine-301566293.html